✦ LIBER ✦

The economics of treating chronic hepatitis C patients with peginterferon α-2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferase

✍ Scribed by J. Hornberger; P. Farci; D. Prati; S. Zeuzem; J. Green; K. K. Patel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of chronic hepatitis C patient

✍ SANJEEV ARORA; CHRISTOPHER O'BRIEN; STEFAN ZEUZEM; MITCHELL L SHIFFMAN; MOISES D 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Peginterferon α-2a (40 KD) plus ribaviri

✍ Makoto Kuboki; Shiro Iino; Tadao Okuno; Masao Omata; Kendo Kiyosawa; Hiromitsu K 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Predicting sustained virological respons

✍ Eric Snoeck; Janet R. Wade; Frank Duff; Matthew Lamb; Karin Jorga 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 739 KB

Comparison of a 6-month course peginterf

✍ S.-D. Lee; M.-L. Yu; P.-N. Cheng; M.-Y. Lai; Y.-C. Chao; S.-J. Hwang; W.-Y. Chan 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

The results of a randomized trial lookin

✍ C. Brandão; A. Barone; F. Carrilho; A. Silva; M. Patelli; C. Caramori; R. Focacc 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

Treatment of chronic he1patitis C genoty

✍ M. DIAGO; A. OLVEIRA; R. SOLÁ; M. ROMERO-GÓMEZ; R. MORENO-OTERO; R. PÉREZ; J. SA 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 539 KB